The Venture Codex

Led · Equity · Jul 2022

Pulsetto develops a hands‑free, wearable device that stimulates the vagus nerve with gentle electrical impulses to shift users from “fight or flight” to “rest and digest.” The device is controlled via a mobile app and is positioned for stress relief, mental resilience, and sleep optimisation. The company says the technology has been validated in the wellness space and has received media exposure, including a Netflix documentary. Pulsetto is now extending its focus into defence and security applications to help soldiers, first responders, and other high‑performance professionals manage stress and sustain cognitive performance. The startup previously raised €400,000 on Lithuanian Shark Tank and secured a €20 million valuation after that round. Most recently it secured additional funding to support the move into dual‑use and defence markets. Pulsetto has launched a wearable, non-invasive vagus nerve stimulation device paired with a mobile app to deliver personalized programs for better sleep, reduced anxiety, and lower stress. The device is intended for home use and is worn for four minutes a couple of times per day. Pulsetto uses a distinct algorithm of electric impulses tuned to specific mixes of voltage and amplitude. The company chose a non-invasive approach rather than implanted devices, citing comparable results and wider access. Pulsetto positions the product as an alternative to medication and time-intensive relaxation techniques. The company announced a €500,000 investment from Kilo Health to develop the product and accompanying app.

Led · Equity · Aug 2021

Medical Score develops patient-oriented digital health products focused on telemedicine, mental health, and AI-based diagnostic platforms. Its initial offerings include a symptom-checker, a health tracker that ingests tracked parameters (heart rate, blood pressure, etc.), and a diagnosis app for patients and doctors. The company also operates an online therapy platform that allows anonymous, frequent contact with therapists and has seen early testing success in the U.S. The startup recently received €1.2 million in funding from Kilo Health, on top of an earlier €1.3 million in early-stage EU funding. The new capital will be used to advance product development across telemedicine, mental-health services, and AI diagnostic tools. Medical Score emphasizes a small, experienced team and a mission of improving access to faster, more informed healthcare decisions.

Led · Seed · Aug 2021

TYLER.HEALTH develops a next-generation continuous glucose monitoring (CGM) sensor paired with a companion app that tracks blood glucose in real time and provides hyper-personalized feedback on how nutrition, exercise, and sleep affect metabolic health. The product combines sensor hardware and advanced analytics to translate biometric data into understandable, actionable insights for weight management, cognitive performance, and chronic disease prevention. The company planned a beta launch of 1,000 CGM sensors and an app release in December 2021. TYLER.HEALTH raised €500,000 in a pre-seed round to fund the beta rollout, accelerate app development, and support further research and product innovation. Leadership includes CEO and co-founder Ignas Survila and CTO/co-founder Edvinas Baublys, with Kasparas Aleknavičius, MD, as Chief of Science and Albinas Plėšnys as Chief of Data. The team emphasizes leveraging advanced data analytics to provide continuous, personalized metabolic-health recommendations and aims to scale access to address global metabolic health challenges.

Led · Equity · Jun 2021

Revolab provides an at-home finger-prick blood test kit and a companion app that returns lab results within 24 hours. Its platform currently supports more than 30 different blood tests, including CBC, glucose, thyroid panels, STD tests, and enzyme markers, plus tailored panels for vegans and vegetarians. The company achieved CE certification for its products, enabling sales across Europe, and reports €100K of pre-orders. Revolab says the pandemic accelerated demand for self-testing, particularly among people with chronic conditions. The founders are Ovidijus Kalinas and Jekaterina Kaliniene; Jekaterina previously served as CEO of Synlab Lithuania. The company is pursuing product development and expansion into EU and US markets.